GCB 70 Efficacy & Safety Conclusions

Clinically proven safe and effective for the management of healthy weight (100 subjects)

Efficacy Conclusions

Body weight: Mean body weight was significantly (p = 0.000**) reduced & the decrease in mean body weight was 6%. Reduction in body weight was observed in both male and female subjects. 97% of the total study population showed a decrease in body weight on completion of the treatment.
Body mass index (BMI): 96% of the study population reported a reduction in BMI. The reduction in BMI was statistically significant on completion of the treatment as compared to the baseline levels (p = 0.000**). The decrease in BMI on completion of the treatment was 5.65% of the baseline value.
Waist circumference: The waist circumference was decreased in 98% of the study population. A waist circumference of the male subjects was reduced up to 6.77%. Female subjects showed a reduction of 6.62% as compared to the respective baseline values.
Plasma leptin levels: The plasma leptin levels were decreased in 99% of the study population. The decrease was statistically significant (13.59%) on completion of the treatment as compared to the baseline value.

Safety Conclusions

On completion of the study, safety conclusions were made and it was found that there were no adverse effects observed during the study. The study population was completely safe during and after the completion of the treatment. No abnormal alterations in the biochemical and hematological parameters were observed on completion of the treatment.

Any Query?